Sandro Santagata
@SantagataMDPhD
Followers
1K
Following
3K
Media
129
Statuses
368
Physician Scientist - Pathologist | @Harvard_Lab | @MGBpathology
Mass General Brigham
Joined October 2014
Excited to see our work finally out in @naturemethods! Amazing work led by Clarence Yapp, @ajitjohnson_n and all co-authors @alexwong2023 @JuliannTefft @LlopisMontero @SantagataMDPhD @sorger_peter @Harvard_Lab. Check it out
Highly multiplexed 3D profiling of cell states and immune niches in human tumors @naturemethods @harvardmed 🇺🇸 https://t.co/nJ4EQtJYL5
0
4
14
September’s academic rush is in full swing, but pausing here to celebrate my colleague Scott Rodig’s groundbreaking study: https://t.co/DALJ3puj35. This 3+ year prospective study of multiplexed immunofluorescence in a CLIA lab integrated into EMR (for over 2,000 patients!),
ascopubs.org
PURPOSERetrospective studies have found associations between the number of intratumoral immune cells and patient outcomes for specific cancers treated with targeted therapies. However, the clinical...
1
3
15
Delighted to share moments from the Harvard Medical School retreat with the Bertarelli Rare Cancer Initiative (BRCI), led by Dr. Marcia Haigis and Dr. George Demetri. 📸Pictured are members of the BRCI team with Dona Bertarelli, whose visionary support through the Bertarelli
0
3
16
Exciting news! Congratulations Linda Bi and team on "Distribution of copy number alterations and impact of chromosome arm call thresholds for meningioma" now published in @NatureComms Check it out and share: https://t.co/viXn3Mfz1t This study reveals that copy number
0
1
8
This interview from the Soledad O'Brien Show captures some of the issues for women's health and our lab's cancer research affected by the termination of federal grants at Harvard and elsewhere https://t.co/QDmVSPbTQt
@harvardmed @AACR
8
13
29
Don't miss this study in @JCI_insight showing #Imlunestrant, a next-generation oral #SERD, overcoming #ESR1 mutant resistance in estrogen receptor-positive #BreastCancer. 🔓 https://t.co/R7JvdVFlHZ
@NardoneAgostina @CapucineHeraud @SKabrajiMD @SantagataMDPhD @DrFanning @RMJesel
1
13
23
Beautiful work @TanjinaKader !!
🚨🚨Paper out!! 🚨🚨 Excited to share our work (Pre-cancer Atlas of High Grade Serous Ovarian Cancer (HGSOC)), now published in @CD_AACR! https://t.co/7wips4hj5y What if I told you HGSOC often starts in the Fallopian Tube and progresses through precancerous lesions? 1/n 🧵👇
0
1
5
Despite the unprecedented challenges we are facing in 2025, I am in awe of our Harvard Medical School team keeping their laser-focus on game-changing medical discoveries. I am immensely proud of their hard work – day and night – nailing what we do best: · Pioneering biomarkers
1
2
31
Ludwig @harvardmed's @JiaRenLin, researcher in @sorger_peter’s lab at the Center, shares how partnership with @SantagataMDPhD and others at the Center has supercharged their work on the high-dimensional imaging of cancerous tissues. #CancerChat
https://t.co/h6NMLIWVTS
1
3
5
Now in @CD_AACR: Multimodal Spatial Profiling Reveals Immune Suppression & Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma - by @TanjinaKader, @JiaRenLin, Clemens Hug, @ronny_drapkin, @SantagataMDPhD, et al. https://t.co/gKIcfB0mGT
2
24
85
This paper is the result of an incredibly fun collaboration with @SantagataMDPhD and Peter Sorger. Led by the fantastic @TanjinaKader with @JiaRenLin, we provide a pre-cancer atlas of Fallopian tube precursors to HGSOC. Don't miss our cbioportal entry of all the data!
Now in @CD_AACR: Multimodal Spatial Profiling Reveals Immune Suppression & Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma - by @TanjinaKader, @JiaRenLin, Clemens Hug, @ronny_drapkin, @SantagataMDPhD, et al. https://t.co/gKIcfB0mGT
3
10
38
Congratulations Azra! Looking forward to your outstanding leadership!
The American Board of Medical Genetics and Genomics Board of Directors is pleased to announce the appointment of Azra Ligon, PhD, FACMG, as its new Chief Executive Officer, effective January 1, 2025. Read more on her background here: https://t.co/8PO1nAv7j9
1
0
4
Mikko Taipale, Michael A. Erb, and Xin Zhou discussed "Emerging Frontiers in Bivalent Degraders" in a special #AACRCICR-organized session at the AACR Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry. #AACRchem24 @mike_tilapia @Michael_A_Erb
2
4
17
Folks, We have a new activity study Calle dBetter Breaks. Check it out. You need to be in the Bay Area to participate.
0
3
9
I’m excited to share SubCell–a suite of vision #ML models for #microscopy to capture single-cell biology. 🌟SubCell provides deep, image-driven representations of cellular architecture across biological contexts & datasets. https://t.co/nZy9g6Jxib
@ProteinAtlas @cziscience
1
39
140
It's exciting to see our field getting the spotlight and recognition it deserves. Great work by the editors and all of the authors involved!! But I wonder if we need to reconsider the general term that is used for these methods ... "spatial proteomics" I don't view our
It was an absolute dream to help with this Method of the Year! SPATIAL PROTEOMICS gets a well-deserved spotlight! Thanks so much to all the authors who contributed their comments! @RongFan8 @BodenmillerLab @leeat_keren @labs_mann @DanielaQuail
1
5
17
It is an absolute joy and honor to work which such extraordinary colleagues every day. Multidisciplinary team science is the way.
Excited to announce Sandro Santagata as the new Associate Director of the Lab of Systems Pharmacology @HarvardMed! As a pathologist and cell biologist, Sandro brings a clinical perspective to our research. Read about his journey & vision for the future: https://t.co/bD2DAVLHIm
6
3
38
Fantastic flash talks by Svetlana Djirackor, Tian-Li Wang, Tanjina Kader, Monica Haughan at the @OCMF_Conference in Sioux Falls. @TanjinaKader @SantagataLab
@shenhui1986 @JBurdetteLab @SanfordResearch
0
4
16
Join our Team at Harvard Medical School for an Outstanding Opportunity for Post-doctoral Training in #SpatialBiology Focusing on #Sarcomas - Biological Discovery, Translation Research, Clinical Trials. POST-DOCTORAL FELLOW IN TRANSLATIONAL CANCER RESEARCH - SARCOMA To apply,
0
13
26